SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-063155
Filing Date
2020-05-18
Accepted
2020-05-18 16:02:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2019231d1_424b5.htm 424B5 442489
2 GRAPHIC tm2019231d1_424b5img01.jpg GRAPHIC 13027
3 GRAPHIC tm2019231d1_424b5img02.jpg GRAPHIC 45024
  Complete submission text file 0001104659-20-063155.txt   523839
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-225878 | Film No.: 20889480
SIC: 2834 Pharmaceutical Preparations